Stroke is more common than myocardial infarction in hypertension: Analysis based on 11 major randomized intervention trials

Blood Pressure

Volumn 10, Issue 4, 2001, Pages 190-192

  Kjeldsen, S E ^a   Julius, S ^a   Hedner, T ^a   Hansson, L ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR RISK; CLINICAL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STROKE; SUDDEN DEATH; UNSTABLE ANGINA PECTORIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; STANDARD;

CEREBROVASCULAR ACCIDENT; HUMANS; HYPERTENSION; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS;

EID: 0035212406     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050152669684     Document Type: Review

References (18)

1. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease
2. The Framingham Study. The epidemiology of atherosclerotic disease
3. Blood pressure, stroke, and coronary heart disease, part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
4. Blood pressure, stroke, and coronary heart disease, part 2, short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context
5. Morbidity and mortality in the Swedish Trial in Old Patients with hypertension (STOP-Hypertension)
6. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
7. Medical Research Council trial of treatment of hypertension in older adults: Principal results
8. Shanghai trial of nifedpine in the elderly (STONE)
9. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
10. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group
11. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
12. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPP) randomised trial
13. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
14. Major cardiovascular events in hypertensive patients randomised to doxazosin vs chlorthalidone. The Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT)
15. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives
16. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) Study
17. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)